Co-reporter:Stephen C. Johns, Laurie L.E. Crouch, Stephen Grieve, Holly L. Maloney, Gary R. Peczkowski, Allison E. Jones, Duncan Sharp, Robert B. Smith
Tetrahedron Letters 2014 Volume 55(Issue 22) pp:3308-3311
Publication Date(Web):28 May 2014
DOI:10.1016/j.tetlet.2014.04.035
Microwave irradiation was applied to a sequence of condensation reactions from readily available 9-chloroacridines to provide a range of novel acridine–isoalloxazine conjugates. The combination of these two moieties, both of biological interest, was achieved by a chromatography-free route.
Co-reporter:Andrew R. Tyler, Adeyi Okoh Okoh, Clare L. Lawrence, Vicky C. Jones, Colin Moffatt, Robert B. Smith
European Journal of Medicinal Chemistry 2013 Volume 64() pp:222-227
Publication Date(Web):June 2013
DOI:10.1016/j.ejmech.2013.03.031
•Synthesis of N-alkylated 2,3,3-trimethylindolenines and 2-methylbenzothiazoles.•Compounds were tested for their antifungal activity.•Structure–activity relationship assessed using statistical analyses.•Strong relationship between chain length and growth inhibition.The synthesis of a variety of N-alkylated 2,3,3-trimethylindolenines and 2-methylbenzothiazoles is reported herein. Their potential as antifungal agents is evaluated by preliminary screening against Saccharomyces cerevisiae (S. cerevisiae), Schizosaccharomyces pombe (S. pombe), and Candida albicans (C. albicans). Statistical analyses illustrate a strong relationship between chain length and growth inhibition for S. cerevisiae and S. pombe (p < 0.0001 in every case).Of particular interest is the activity of both sets of compounds against S. cerevisiae, as this is emerging as an opportunistic pathogen, especially in immunosuppressed and immunocompromised patients. Bioassays were set up to compare the efficacy of our range of N-alkylated compounds against classic antifungal agents; Amphotericin B and Thiabendazole.